Effective as of January 10, 2024, Dr. Neil Campbell resigned as President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Onconetix, Inc. (the “Company”).
On January 12, 2024, the Board appointed Dr. Ralph Schiess, the Company’s Chief Science Officer, to serve as the Company’s Interim Chief Executive Officer.
Departed
Leonid Gontmakher
Chief Executive Officer
4Front Ventures Corp.
Effective
2024-01-08
Successor
Andrew Thut
Filed
January 12, 2024, 6:59 PM ET
Effective January 8, 2024, Leonid Gontmakher resigned as Chief Executive Officer of 4Front Ventures Corp. (the “Company”).
Role change
Andrew Thut
Chief Executive Officer
4Front Ventures Corp.
Effective
2024-01-08
Filed
January 12, 2024, 6:59 PM ET
Effective January 8, 2024, the Company promoted Andrew Thut to Chief Executive Officer of the Company.
The effective date of Mr. Wintrob’s cessation of service as chief executive officer of OCG and a member of the board of directors of OCG has been determined to be March 1, 2024.
On January 10, 2024, Simon Stadil tendered his resignation as Chief Financial Officer of LiqTech International, Inc. (the " Company "), effective as of April 10, 2024.
In connection with Mr. Talley’s appointment to President and Chief Executive Officer, Mr. Doug Cole resigned from the President and Chief Executive Officer roles of the Company, but still maintains his roles as Executive Chairman and Chief Financial Officer.
On December 11, 2023, M2i Global, Inc. (“the Company”) appointed Lieutenant General (Ret) Jeffrey W. Talley, age 64, as President and Chief Executive Officer of the Company.
Effective January 12, 2024, The Marygold Companies, Inc. (the “Company”) has accepted the resignation of Stuart P. Crumbaugh on the Company’s Board of Directors and as its chief financial officer.
Additionally, on January 9, 2024, John “JT” Thatch has been appointed to the Chief Executive Officer of the Company.
Departed
Patrick L. Bridges
Senior Vice President and Chief Financial Officer
Tri-State Generation & Transmission Association, Inc.
Successor
Todd Telesz
Filed
January 12, 2024, 6:59 PM ET
Patrick L. Bridges, our Senior Vice President and Chief Financial Officer, informed us that he intends to retire in March 2024 after more than 17 years of service to us.
Appointed
Todd Telesz
Senior Vice President and Chief Financial Officer
Tri-State Generation & Transmission Association, Inc.
Effective
2024-01-29
Filed
January 12, 2024, 6:59 PM ET
On January 12, 2024, Todd Telesz, age 52, accepted the position to succeed Mr. Bridges as our Senior Vice President and Chief Financial Officer effective January 29, 2024.
On January 9, 2024, the Company’s Board of Directors (the “Board”) appointed Lawrence R. Hoffman as Interim Chief Financial Officer of the Company effective January 11, 2024
Effective as of January 8, 2024, the Board appointed Dr. Steve Niu as the CFO of the Company, until the next annual meeting of the Company’s stockholders, and until his successor is elected and qualified or until his prior death, resignation or removal.
On January 10, 2024, the Board of Directors (the “Board”) of SeaStar Medical Holding Corporation (the “Company”) appointed David Green, age 61, as the Company’s Chief Financial Officer, effective as of January 10, 2024.
On January 10, 2024, Flexsteel Industries, Inc. (the “Company”) announced that Michael J. Ressler has been promoted to assume the role of Chief Financial Officer, Treasurer & Secretary effective immediately.
On January 10, 2024, in connection with Derek P. Schmidt being appointed President, Jerald K. Dittmer is relinquishing his position as President and will continue to serve as the Chief Executive Officer.
Mr. Franklin K. Clyburn, Jr. who is currently Chief Executive Officer (“CEO”) of the Company and a director of the Company’s Board of Directors (the “Board”), will cease to serve as CEO and a director of the Board, effective February 6, 2024.
On January 7, 2024, the board of directors (the “Board”) of XOMA Corporation, a Delaware corporation (the “Company”), appointed Owen Hughes, previously Interim Chief Executive Officer, to serve as the Company’s Chief Executive Officer and to continue serving as principal executive officer and a director, effective immediately.
On January 8, 2024, biote Corp. (the “Company”) appointed Robert Peterson as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
On January 5, 2024, George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “ Company ”) effective April 4, 2024.
Departed
David Roman
President and Chief Executive Officer
Acutus Medical, Inc.
Effective
2024-01-07
Successor
Takeo Mukai
Filed
January 11, 2024, 6:59 PM ET
David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.
Appointed
Takeo Mukai
Chief Executive Officer
Acutus Medical, Inc.
Effective
2024-01-08
Filed
January 11, 2024, 6:59 PM ET
the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.
Appointed
Cheskel Meisels
Chairman of the Board and Chief Executive Officer
Fuss Brands Corp.
Effective
2024-01-10
Filed
January 11, 2024, 6:59 PM ET
Also on January 10, 2024, the shareholders of the Company elected Cheskel Meisels to act as the new Chairman of the Board of Directors of the Company.
Departed
Issamar Ginzberg
Chief Executive Officer and Director
Fuss Brands Corp.
Effective
2024-01-10
Successor
Cheskel Meisels
Filed
January 11, 2024, 6:59 PM ET
On January 10, 2024, Issamar Ginzberg tendered his resignation from the Board of Directors of Fuss Brands Corp.
On January 05, 2024, Kevin L. Brackman, Chief Financial Officer of Advent Technologies Holdings, Inc., a Delaware corporation (the “Company” or “Advent”), resigned from all of his positions at the Company and its subsidiaries, effective immediately.
the Board of Directors of the Company (the “Board”) on January 10, 2024, appointed Naiem Hussain, 56, the Company’s current Chief Investment Officer, to serve as Chief Financial Officer of the Company, pending the completion of the Company’s hiring protocols.
Appointed
Jerome E. Schwind
President and Chief Executive Officer of Isabella Bank Corporation and Chief Executive Officer of Isabella Bank
Subsequently, the election of Jerome E. Schwind to President and Chief Executive Officer of the Corporation and Chief Executive Officer of Isabella Bank was effective January 5, 2024.
Departed
Jae A. Evans
President and Chief Executive Officer of Isabella Bank Corporation and Chief Executive Officer of Isabella Bank
On January 4, 2024, Jae A. Evans retired as President and Chief Executive Officer of Isabella Bank Corporation (the “Corporation”) and Chief Executive Officer of Isabella Bank.
Appointed
(interim)
Samuel Berry
Interim Chairman, Chief Executive Officer, President and Secretary
CuraScientific Corp.
Effective
2023-12-29
Filed
January 10, 2024, 6:59 PM ET
On December 29, 2023, the Board of Directors of the Company appointed Samuel Berry to serve as the Interim Chairman of the Board of the Company, Chief Executive Officer, President and Secretary.
Departed
William Reed
Chairman, CEO, Secretary and Treasurer
CuraScientific Corp.
Effective
2023-12-29
Successor
Samuel Berry
Filed
January 10, 2024, 6:59 PM ET
On December 29, 2023 William Reed resigned as Chairman, CEO, Secretary and Treasurer from Curascientific Corporation, (the “Company”).
On January 9, 2024, Ron Shelton, Senior Vice President, Chief Financial Officer and Treasurer of Navitas Semiconductor Corporation (“Navitas” or the “Company”), announced his intention to pursue other opportunities effective March 15, 2024.
Appointed
Janet Chou
Executive Vice President, Chief Financial Officer and Treasurer
On January 10, 2024, the Company announced the appointment of Janet Chou as Executive Vice President, Chief Financial Officer and Treasurer, effective upon the filing of the Company’s annual report on Form 10‐K for the year ended December 31, 2023, which is expected on or before February 29, 2024.
the Board appointed Brett R. Larsen, the Company’s Executive Vice President of Administration, Chief Financial Officer and Treasurer, to succeed Mr. Gates as the Company’s President and Chief Executive Officer effective upon Mr. Gates’ retirement on June 30, 2024.
Craig D. Gates, the President and Chief Executive Officer and member of the Board of Directors (the “Board”) of Key Tronic Corporation (the “Company”), notified the Board of his decision to retire as President and Chief Executive Officer effective June 30, 2024.
Appointed
Anthony G. Voorhees
Executive Vice President of Administration, Chief Financial Officer and Treasurer
the Board appointed Anthony G. Voorhees, the Company’s Vice President of Finance and Controller, to succeed Mr. Larsen as the Company’s Executive Vice President of Administration, Chief Financial Officer and Treasurer effective on June 30, 2024.
On January 3, 2024, Sonos, Inc. (the “Company”) appointed Saori Casey as Chief Financial Officer (“CFO”) and principal financial officer, effective as of January 22, 2024 (the “Effective Date”).
the Company’s Board of Directors (the “Board”) appointed Massimo Calafiore as the Company’s President and Chief Executive Officer, and Mr. Calafiore began service on such date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.